“Rob and Seth are great additions to the Board of Directors. I look forward to working with them, and John in his new role, to create value for Harvard Bioscience’s shareholders. On behalf of the ...

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...

Figure: 1 Palisade Bio, Inc. Appoints Emil Chuang, MB BS FRACP to its Board of Directors Veteran clinical leader with successful track record and experience to help guide the Company’s clinical ...

Palisade Bio appoints Dr. Emil Chuang to its Board of Directors, enhancing clinical strategy for Crohn's Disease and Ulcerative Colitis.

Palisade Bio continues to develop novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, with a keen interest in transforming treatment landscapes.

CARLSBAD, California - Palisade Bio, Inc. (NASDAQ:PALI), a clinical-stage biopharmaceutical company focused on autoimmune, inflammatory, and fibrotic diseases, announced Wednesday the appointment of ...

Carlsbad, CA, July 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade”, "Palisade Bio”, or the "Company”), a clinical-stage biopharmaceutical company advancing novel ...

Carlsbad, CA, July 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel ...

Faced with a medical establishment that doesn’t serve them, a volatile political environment, and a technological revolution, ...

The White River Alliance held its monthly meeting for July last week at the Heritage Culture Center in Meeker, where board ...

An AI-generated influencer named Mia Zelu has gained significant attention for posting content from Wimbledon, accumulating over 160,000 followers despite never actually attending the tournament.